Instadose Pharma (Instadose Pharma) FCF Margin % : 0.00% (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Instadose Pharma's Free Cash Flow for the three months ended in Feb. 2022 was $0.13 Mil. Instadose Pharma's Revenue for the three months ended in Feb. 2022 was $0.00 Mil. Therefore, Instadose Pharma's FCF Margin % for the quarter that ended in Feb. 2022 was 0.00%.

As of today, Instadose Pharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Instadose Pharma's FCF Margin % or its related term are showing as below:

INSD's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.195
* Ranked among companies with meaningful FCF Margin % only.

Instadose Pharma FCF Margin % Historical Data

The historical data trend for Instadose Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma FCF Margin % Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

FCF Margin %

Get a 7-Day Free Trial

-100.00

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Instadose Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instadose Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's FCF Margin % falls into.

Instadose Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Instadose Pharma's FCF Margin for the fiscal year that ended in Nov. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Nov. 2021 )	/	Revenue (A: Nov. 2021 )
	=	0	/	0
	=	%

Instadose Pharma's FCF Margin for the quarter that ended in Feb. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Feb. 2022 )	/	Revenue (Q: Feb. 2022 )
	=	0.126	/	0
	=	%

Instadose Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.